These findings suggest that PPARα activation exacerbates cardiac functional impairment and myocardial fibrosis in DCM, while overexpression of GDF11 can alleviate the effects of PPARα activation. The gene discussed is PPARA; the disease is familial dilated cardiomyopathy.